About: Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report
Creator	Ji, Mingyu Pei, Fengyan Wang, Yunshan Wang, Jun Li, H Li, Qiang Wang, Y Kumar, Binod Han, Shuyi Wang, Qingxi Zhao, Qianqian Zhou, Yunying Wang, Yangyang Efroni, Sol Giuliano, Mariateresa Hong, Yatian Li, Huanjie
Source	Medline; PMC
abstract	The global outbreak of SARS-CoV-2 spread rapidly throughout the world which transmitted among humans through various routes. Asymptomatic (carriers) and possible fecal-oral transmission, resulted into a large-scale spread. These issues pose great challenges to disease diagnosis and epidemic control. We obtained data on 29 cases of COVID-19 patients in Jinan, China, and reported the clinical data of asymptomatic patients confirmed with stool samples positive. Some patients with gastrointestinal infections are secondary to pulmonary infections, and during the patients' recovery period, the virus may still existin the patient's gastrointestinal tract over 7 days. We combined with epidemiological and clinical data of asymptomatic patients to analyze the possible routes of viral transmission and infection, including eyes-nose, hands-eyes, fecal-oral, and eyes-oral, et al., thus first presented the two-way transmission through eyes-oral. Through associating infection symptoms with the transmission routes of virus and the patient course of the disease, we expect to provide guidelines for clinical diagnosis and the basis for suppressing the spread of the virus and antiviral treatment.
has issue date	2020-07-10(xsd:dateTime)
bibo:doi	10.3389/fcell.2020.00618
bibo:pmid	32754600
has license	cc-by
sha1sum (hex)	d930dcbe6be86c24c85eb4c937e8a6cbb8eab354
schema:url	https://doi.org/10.3389/fcell.2020.00618
resource representing a document's title	Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report
has PubMed Central identifier	PMC7365854
has PubMed identifier	32754600
schema:publication	Front Cell Dev Biol
resource representing a document's body	covid:d930dcbe6be86c24c85eb4c937e8a6cbb8eab354#body_text
is schema:about of	named entity 'antiviral treatment' named entity 'asymptomatic' named entity 'NOSE' named entity 'CHINA' named entity 'WAY' named entity 'FECAL' named entity 'diagnosis' named entity 'infections' named entity 'Jinan' named entity 'gastrointestinal tract' named entity 'routes' named entity 'infection' named entity 'routes' named entity 'fecal-oral' named entity 'COVID-19' named entity 'Asymptomatic' named entity '7 days' named entity 'asymptomatic' named entity 'virus' named entity 'asymptomatic patients' named entity 'fecal-oral' named entity 'asymptomatic patients' named entity 'virus' named entity 'recovery period' named entity 'fecal-oral transmission' named entity 'China' named entity 'Case Report' named entity 'Systematic Review' named entity 'SARS-CoV-2' named entity 'IL17' named entity 'lungs' named entity 'nasal cavity' named entity 'Clinical characteristics' named entity 'Medical Ethics' named entity 'glycoprotein' named entity 'nasopharynx' named entity 'infection' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'respiratory symptoms' named entity 'Il-8' named entity 'virus' named entity 'fever' named entity 'symptom' named entity 'nucleic acid' named entity 'nucleic acid testing' named entity 'cell phone' named entity 'infectious diseases' named entity 'feces' named entity 'nasolacrimal duct' named entity 'viral transmission' named entity 'MERS-CoV' named entity 'epithelial cells' named entity 'virus' named entity 'epidemic' named entity 'pulmonary infection' named entity 'Jinan' named entity 'lung infection' named entity 'virus' named entity 'nucleocapsid' named entity 'SARS-CoV-2' named entity 'viruses' named entity 'infection' named entity 'Jinan' named entity 'COVID-19'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software